Why the study?
Do angiopoietin-like proteins regulate lipoprotein metabolism and affect cardiovascular events?
Population
Humans (population-based studies and patients with metabolic syndrome) and mice
Design
Review
Authors
Loading...
May guide ANGPTL inhibitor development for hypertriglyceridemia; leaves open cardiovascular event reduction in trials.
Do angiopoietin-like proteins regulate lipoprotein metabolism and affect cardiovascular events?
Angptl3, Angptl4, and Angptl5 are important regulators of lipoprotein metabolism, highlighting their potential as therapeutic targets for dyslipidemia and cardiovascular disease prevention.
Miida et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: